Harbour Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,919
Closed -$471K 253
2018
Q2
$471K Sell
5,919
-2,294
-28% -$190K 0.2% 134
2018
Q1
$733K Sell
8,213
-5,297
-39% -$509K 0.31% 100
2017
Q4
$1.41M Sell
13,510
-267
-2% -$30.1K 0.59% 53
2017
Q3
$2.01M Buy
13,777
+1,555
+13% +$212K 0.88% 25
2017
Q2
$1.59M Buy
12,222
+25
+0.2% +$3.06K 0.79% 30
2017
Q1
$1.52M Buy
12,197
+83
+0.7% +$9.93K 0.69% 31
2016
Q4
$1.4M Buy
12,114
+850
+8% +$94.7K 1.01% 23
2016
Q3
$1.18M Buy
11,264
+465
+4% +$50.3K 0.74% 32
2016
Q2
$1.06M Sell
10,799
-80
-0.7% -$8.28K 0.6% 44
2016
Q1
$1.09M Sell
10,879
-166
-2% -$17.1K 0.62% 42
2015
Q4
$1.32M Buy
11,045
+910
+9% +$105K 0.72% 32
2015
Q3
$1.1M Buy
10,135
+1,390
+16% +$172K 0.78% 34
2015
Q2
$1.01M Buy
8,745
+2,000
+30% +$229K 0.63% 48
2015
Q1
$778K Buy
6,745
+1,675
+33% +$200K 0.54% 62
2014
Q4
$567K Hold
5,070
0.41% 89
2014
Q3
$481K Buy
+5,070
New +$458K 0.4% 97

Other funds holding CELG

Harbour Capital Advisors's CELG Position: Q3 2018 in Review

Harbour Capital Advisors sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 5,919 shares — an estimated $471K sold.

Harbour Capital Advisors first reported a position in CELG in Q3 2014 and held it in 16 quarters. The position peaked at $2.01M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Harbour Capital Advisors reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Harbour Capital Advisors sold 5,919 Celgene Corp shares in Q3 2018, an estimated $471K.
  • Harbour Capital Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 16 quarters.
  • Harbour Capital Advisors's Celgene Corp position peaked at $2.01M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Harbour Capital Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.